Table of Contents
ISRN Oncology
Volume 2011, Article ID 168712, 10 pages
http://dx.doi.org/10.5402/2011/168712
Research Article

High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour Patients

1Department of Pathology, Haartman Institute and HUSLAB, University of Helsinki and Helsinki University Central Hospital, 00014, Helsinki, Finland
2Department of Information and Computer Science, Aalto University School of Science, 02015, Espoo, Finland
3Laboratorio di Ricerca Oncologica, Istituti Ortopedici Rizzoli, 40136, Bologna, Italy
4Hematology Research Unit, Helsinki University Central Hospital, P.O. Box 700, 00290, Helsinki, Finland

Received 1 July 2011; Accepted 24 July 2011

Academic Editors: B. Comin-Anduix and K. Sonoda

Copyright © 2011 Suvi Savola et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Suvi Savola, Arto Klami, Samuel Myllykangas, et al., “High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour Patients,” ISRN Oncology, vol. 2011, Article ID 168712, 10 pages, 2011. https://doi.org/10.5402/2011/168712.